Acquisition Positions Amneal to Capitalize on $300B+ Global Biologics LOE Opportunity –– Transaction Accelerates Growth Profile and ...

Kashiv BioSciences, LLC ("Kashiv"), today announced that it has entered into a definitive agreement to be acquired by Amneal ...

Union Minister Nitin Gadkari on Wednesday said there is a need to create employment opportunities in rural and tribal areas ...

The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.

The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.

India’s green transition hinges not on breakthrough innovation alone, but on building deep, reliable value chains that turn ...

The first clips from “As Deep as the Grave” feature an AI-generated version of Val Kilmer, who died in 2025. The filmmakers ...

McGill researchers are translating biological assembly strategies into scalable, lower-impact alternatives to synthetic ...

The company, which has had its pool verified by classification society DNV, said its first FuelEU pool included several ...

Typically, engineers perform surgery to implant electrodes into the insects’ antennae. The antennae contain sensors for smell ...

After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey ...